Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris

Inclusion Criteria: * Participants aged from 18 to 65 years old, male, or female with no childbearing potential or who are using an effective contraceptive method and who do not plan to become pregnant during the study period. * Presence of dermatological lesion of Tinea cruris, with an area not exceeding 8 cm², having, also, the diagnosis confirmed by direct mycological (KOH) test and fungus culture. * No previous treatment with antimycotic medication for the current dermatologic lesion. * No evidence of other significant diseases, that, at the investigator's discretion, may affect the participation in the clinical trial, in accordance with the protocol requirements. * Ability to understand the nature and the objective of the clinical trial, including the risks and possible side effects; intention to cooperate with the investigator and act in accordance with the protocol requirements, as confirmed by the informed consent form signature. Exclusion Criteria: * Known hypersensitivity to miconazole or to chemically related compounds (azoles) or to the compounds of the investigational products. * Existing hepatic and/or renal diseases or other pathologic findings, which might interfere with the safety and tolerability of the active ingredients. * Screening laboratory tests presenting deviations deemed as clinically significant, which, due to possible risks, prevents the participation in clinical trial. * Treatment, within 3 months prior to the start of the clinical trial treat…